|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Loans held for sale, at fair value (includes $802,806 and $606,215 pledged to creditors in securitization trusts at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Pledged as Collateral | ||||||||||||||||||||
| Total loans held for sale, at fair value (includes $802,806 and $606,215 pledged to creditors in securitization trusts at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Loans held for investment, at fair value (pledged to creditors in a securitization trust) | ||||||||||||||||||||
| Derivative assets, at fair value | ||||||||||||||||||||
| Servicing rights, at fair value (includes $696,417 and $661,475 pledged to creditors in securitization trusts at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Pledged as Collateral | ||||||||||||||||||||
| Total servicing rights, at fair value (includes $696,417 and $661,475 pledged to creditors in securitization trusts at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Trading securities, at fair value | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Loans eligible for repurchase | ||||||||||||||||||||
| Investments in joint ventures | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Warehouse and other lines of credit | ||||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||||||
| Derivative liabilities, at fair value | ||||||||||||||||||||
| Liability for loans eligible for repurchase | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Debt obligations, net | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock, par value (in usd per share) | ||||||||||||||||||||
| Common stock issued (in shares) | ||||||||||||||||||||
| Class A | ||||||||||||||||||||
| Class B | ||||||||||||||||||||
| Class C | ||||||||||||||||||||
| Class D | ||||||||||||||||||||
| Common stock authorized (in shares) | ||||||||||||||||||||
| Preferred stock authorized (in shares) | ||||||||||||||||||||
| Preferred stock issued (in shares) | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Common stock | ||||||||||||||||||||
| Class A | ||||||||||||||||||||
| Class B | ||||||||||||||||||||
| Class C | ||||||||||||||||||||
| Class D | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 50,000,000 authorized, none issued at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Treasury stock at cost, 10,342,938 and 8,779,081 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained deficit | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
